| REGISTERED NUMBER: |
| Strategic Report, Report of the Director and |
| Financial Statements for the Year Ended 31 March 2026 |
| for |
| APPLECROSS NURSING HOME LIMITED |
| REGISTERED NUMBER: |
| Strategic Report, Report of the Director and |
| Financial Statements for the Year Ended 31 March 2026 |
| for |
| APPLECROSS NURSING HOME LIMITED |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Contents of the Financial Statements |
| for the Year Ended 31 March 2026 |
| Page |
| Company Information | 1 |
| Strategic Report | 2 |
| Report of the Director | 3 |
| Report of the Independent Auditors | 5 |
| Statement of Comprehensive Income | 9 |
| Balance Sheet | 10 |
| Statement of Changes in Equity | 11 |
| Notes to the Financial Statements | 12 |
| APPLECROSS NURSING HOME LIMITED |
| Company Information |
| for the Year Ended 31 March 2026 |
| DIRECTOR: |
| SECRETARY: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| SENIOR STATUTORY AUDITOR: |
| AUDITORS: |
| Statutory Auditor |
| 29 Brandon Street |
| Hamilton |
| ML3 6DA |
| SOLICITORS: |
| 110 Queen Street |
| Glasgow |
| G1 3BX |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Strategic Report |
| for the Year Ended 31 March 2026 |
| The director presents her strategic report for the year ended 31 March 2026. |
| REVIEW OF BUSINESS |
| In the opinion of the board of directors, the company has achieved excellent results of the year under review, despite the difficult market conditions affecting the sector generally. The results for the financial year reflect continued investment in the business. A summary of results is as follows: |
| 31st March 2026 | 31st March 2025 |
| Turnover | £6,491,122 | £5,987,541 |
| Profit after taxation | £768,795 | £490,720 |
| Gross Profit | £2,365,391 | £2,199,715 |
| Gross profit percentage | 36.44% | 36.74% |
| Shareholders' funds amount to £3,992,236 (2025 - £3,610,294). The directors are confident that the company has sufficient reserves to finance the anticipated levels of activity in the future. |
| Turnover for the year ended 31 March 2027 is likely to improve, and the board is satisfied that, with tight control of margins generated, careful monitoring of overheads and continued investment in the business coupled with excellent service provision, profitability will continue at satisfactory levels. The directors therefore expect a continued positive financial performance in the normal course going forward. |
| There have been no events since the balance sheet date that materially affect the financial position of the company. |
| GOING CONCERN |
| The directors have assessed the company as having sufficient resources to meet the expected ongoing costs of the business for a period of at least 12 months from the date of signing the financial statements. As a result they have continued to adopt the going concern basis when preparing the financial statements. |
| PRINCIPAL RISKS AND UNCERTAINTIES |
| The company operates in the nursing home industry and is therefore subject to the trading cycles that occur in that sector. The market is competitive although the company has a good reputation with local and regulatory authorities and therefore has repeat business and provides specialist care with barriers to entry. The board is confident that the excellent levels of service provided will ensure that the company continues to be competitive in its chosen market. |
| ON BEHALF OF THE BOARD: |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Report of the Director |
| for the Year Ended 31 March 2026 |
| The director presents her report with the financial statements of the company for the year ended 31 March 2026. |
| PRINCIPAL ACTIVITY |
| The principal activity of the company in the year under review was that of nursing home. |
| DIVIDENDS |
| On 30 April 2025 interim dividends were voted as follows:- |
| - Ordinary shares interim dividend of £200 per share |
| The total of interim dividends paid was £400,000. |
| DIRECTORS |
| Other changes in directors holding office are as follows: |
| STATEMENT OF DIRECTOR'S RESPONSIBILITIES |
| The director is responsible for preparing the Strategic Report, the Report of the Director and the financial statements in accordance with applicable law and regulations. |
| Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the director must not approve the financial statements unless she is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to: |
| - | select suitable accounting policies and then apply them consistently; |
| - | make judgements and accounting estimates that are reasonable and prudent; |
| - | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
| The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable her to ensure that the financial statements comply with the Companies Act 2006. She is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. |
| STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
| So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and she has taken all the steps that she ought to have taken as a director in order to make herself aware of any relevant audit information and to establish that the company's auditors are aware of that information. |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Report of the Director |
| for the Year Ended 31 March 2026 |
| AUDITORS |
| The auditors, Sharles Audit Limited, have indicated their willingness to be reappointed for another term and appropriate arrangements have been put in place for them to be deemed reappointed as auditors in the absence of an Annual General Meeting. |
| ON BEHALF OF THE BOARD: |
| Report of the Independent Auditors to the Members of |
| Applecross Nursing Home Limited |
| Opinion |
| We have audited the financial statements of Applecross Nursing Home Limited (the 'company') for the year ended 31 March 2026 which comprise the Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice). |
| In our opinion the financial statements: |
| - | give a true and fair view of the state of the company's affairs as at 31 March 2026 and of its profit for the year then ended; |
| - | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
| - | have been prepared in accordance with the requirements of the Companies Act 2006. |
| Basis for opinion |
| We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. |
| Conclusions relating to going concern |
| In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate. |
| Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. |
| Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report. |
| Other information |
| The director is responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Director, but does not include the financial statements and our Report of the Auditors thereon. |
| Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. |
| In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. |
| Opinions on other matters prescribed by the Companies Act 2006 |
| In our opinion, based on the work undertaken in the course of the audit: |
| - | the information given in the Strategic Report and the Report of the Director for the financial year for which the financial statements are prepared is consistent with the financial statements; and |
| - | the Strategic Report and the Report of the Director have been prepared in accordance with applicable legal requirements. |
| Report of the Independent Auditors to the Members of |
| Applecross Nursing Home Limited |
| Matters on which we are required to report by exception |
| In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Director. |
| We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: |
| - | adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or |
| - | the financial statements are not in agreement with the accounting records and returns; or |
| - | certain disclosures of director's remuneration specified by law are not made; or |
| - | we have not received all the information and explanations we require for our audit. |
| Responsibilities of director |
| As explained more fully in the Statement of Director's Responsibilities set out on page three, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. |
| In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or has no realistic alternative but to do so. |
| Report of the Independent Auditors to the Members of |
| Applecross Nursing Home Limited |
| Auditors' responsibilities for the audit of the financial statements |
| Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. |
| The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: |
| Irregularities are instances of non-compliance with laws and regulations. The objectives of our audit are to obtain sufficient appropriate audit evidence regarding compliance with laws and regulations that have a direct effect on the determination of material amounts and disclosures in the financial statements, to perform audit procedures to help identify instances of non-compliance with other laws and regulations that may have a material effect on the financial statements, and to respond appropriately to identified or suspected non-compliance with laws and regulations identified during the audit. |
| In relation to fraud, the objectives of our audit are to identify and assess the risk of material misstatement of the financial statements due to fraud, to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud through designing and implementing appropriate responses and to respond appropriately to fraud or suspected fraud identified during the audit. |
| However, it is the primary responsibility of management, with the oversight of those charged with governance, to ensure that the entity's operations are conducted in accordance with the provisions of laws and regulations and for the prevention and detection of fraud. |
| In identifying and assessing risks of material misstatement in respect of irregularities, including fraud, the audit engagement team: |
| - obtained an understanding of the nature of the industry and sector, including the legal and regulatory framework that the company operates in and how the company is complying with the legal and regulatory framework; |
| - inquired of management, and those charged with governance, about their own identification and assessment of the risks of irregularities, including any known actual, suspected or alleged instances of fraud; |
| - discussed matters about non-compliance with laws and regulations and how fraud might occur including assessment of how and where the financial statements may be susceptible to fraud. |
| As a result of these procedures we consider the most significant laws and regulations that have a direct impact on the financial statements are FRS 102, the Companies Act 2006 and tax compliance regulations. We performed audit procedures to detect non-compliances which may have a material impact on the financial statements which included reviewing financial statement disclosures, inspecting correspondence with local tax authorities and evaluating advice received from external tax advisors. |
| The most significant laws and regulations that have an indirect impact on the financial statements are those in relation to health and safety, employment law, GDPR, anti-money laundering and environmental regulations. We performed audit procedures to inquire of management and those charged with governance whether the company is in compliance with these law and regulations and reviewed any relevant legal correspondence and invoices for evidence of non compliance. |
| The audit engagement team identified the risk of management override of controls and revenue recognition as the areas where the financial statements were most susceptible to material misstatement due to fraud. Audit procedures performed included but were not limited to performing analytical procedures to identify unusual or unexpected relationships, testing manual journal entries and other adjustments and evaluating the business rationale in relation to significant, unusual transactions and transactions entered into outside the normal course of business, and challenging judgments and estimates applied in the year end accounts. |
| A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors. |
| Report of the Independent Auditors to the Members of |
| Applecross Nursing Home Limited |
| Use of our report |
| This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed. |
| for and on behalf of |
| Statutory Auditor |
| 29 Brandon Street |
| Hamilton |
| ML3 6DA |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Statement of Comprehensive |
| Income |
| for the Year Ended 31 March 2026 |
| 2026 | 2025 |
| Notes | £ | £ |
| TURNOVER |
| Cost of sales |
| GROSS PROFIT |
| Administrative expenses |
| 1,210,224 | 946,567 |
| Other operating income |
| OPERATING PROFIT | 5 |
| Interest payable and similar expenses | 6 |
| PROFIT BEFORE TAXATION |
| Tax on profit | 7 |
| PROFIT FOR THE FINANCIAL YEAR |
| OTHER COMPREHENSIVE INCOME |
| Revaluation release |
| Income tax relating to other comprehensive income |
( |
) |
| OTHER COMPREHENSIVE INCOME FOR THE YEAR, NET OF INCOME TAX |
| TOTAL COMPREHENSIVE INCOME FOR THE YEAR |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Balance Sheet |
| 31 March 2026 |
| 2026 | 2025 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Tangible assets | 9 |
| Investments | 10 |
| CURRENT ASSETS |
| Debtors | 11 |
| Cash at bank and in hand |
| CREDITORS |
| Amounts falling due within one year | 12 |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
13 |
( |
) |
( |
) |
| PROVISIONS FOR LIABILITIES | 17 | ( |
) | ( |
) |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 18 |
| Revaluation reserve | 19 |
| Retained earnings | 19 |
| SHAREHOLDERS' FUNDS |
| The financial statements were approved by the director and authorised for issue on |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Statement of Changes in Equity |
| for the Year Ended 31 March 2026 |
| Called up |
| share | Retained | Revaluation | Total |
| capital | earnings | reserve | equity |
| £ | £ | £ | £ |
| Balance at 1 April 2024 |
| Changes in equity |
| Dividends | - | ( |
) | - | ( |
) |
| Total comprehensive income | - |
| Balance at 31 March 2025 |
| Changes in equity |
| Dividends | - | ( |
) | - | ( |
) |
| Total comprehensive income | - | ( |
) |
| Balance at 31 March 2026 |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Notes to the Financial Statements |
| for the Year Ended 31 March 2026 |
| 1. | STATUTORY INFORMATION |
| Applecross Nursing Home Limited is a |
| The presentation currency of the financial statements is the Pound Sterling (£). |
| 2. | STATEMENT OF COMPLIANCE |
| 3. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| The financial statements have been prepared on a going concern basis. |
| Financial Reporting Standard 102 - reduced disclosure exemptions |
| The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland": |
| • | the requirements of Section 7 Statement of Cash Flows; |
| • | the requirement of paragraph 3.17(d); |
| • | the requirements of paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c); |
| • | the requirements of paragraphs 12.26, 12.27, 12.29(a), 12.29(b) and 12.29A; |
| • | the requirements of paragraphs 26.18(b), 26.19 to 26.21 and 26.23; |
| • | the requirements of paragraphs 29.28(b) and 29.29; |
| • | the requirement of paragraph 33.7; |
| • | the requirements of paragraph 24(b) of IFRS 6. |
| Preparation of consolidated financial statements |
| The financial statements contain information about Applecross Nursing Home Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 400 of the Companies Act 2006 from the requirements to prepare consolidated financial statements as it and its subsidiary undertaking are included by full consolidation in the consolidated financial statements of its parent, Applecross Investments Ltd, c/o Applecross Nursing Home, Levernholm by Hurlet, Glasgow Road, Glasgow, G53 7TG. |
| Significant judgements and estimates |
| In the application of the company's accounting policies, management is required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. |
| Turnover & revenue recognition |
| Turnover is derived from nursing and care services supplied by the company. |
| Turnover is measured at the fair value of nursing and care services supplied, net of discounts and is recognised at the point that the company obtains the right to consideration. |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 3. | ACCOUNTING POLICIES - continued |
| Tangible fixed assets |
| Freehold property | - |
| Plant and machinery | - |
| Fixtures and fittings | - |
| Motor vehicles | - |
| At each balance sheet date, the company reviews the carrying amounts of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. Where it is not possible to estimate the recoverable amount of the asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs. |
| Expenditure of £1,000 or more on individual tangible fixed assets is capitalised at cost. Expenditure on assets below this threshold is charged directly to the income account in the period it is incurred. |
| Investments in subsidiaries |
| Investments in subsidiary undertakings are recognised at cost. |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 3. | ACCOUNTING POLICIES - continued |
| Basic financial instruments |
| The company has elected to apply the provisions of Section 11 'Basic Financial Instruments and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. |
| Basic financial assets |
| Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. |
| Impairment of financial assets |
| Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date. |
| Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss. |
| If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss. |
| Derecognition of financial assets |
| Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party. |
| Classification of financial liabilities |
| Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. |
| Basic financial liabilities |
| Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 3. | ACCOUNTING POLICIES - continued |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Hire purchase and leasing commitments |
| Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter. |
| The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability. |
| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| 4. | EMPLOYEES AND DIRECTORS |
| 2026 | 2025 |
| £ | £ |
| Wages and salaries |
| Social security costs |
| Other pension costs |
| The average number of employees during the year was as follows: |
| 2026 | 2025 |
| Management and Administrative | 7 | 7 |
| Nursing and Care Staff | 103 | 103 |
| Kitchen, Domestic, & Maintenance | 25 | 23 |
| 2026 | 2025 |
| £ | £ |
| Directors' remuneration |
| Directors' pension contributions to money purchase schemes |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 5. | OPERATING PROFIT |
| The operating profit is stated after charging/(crediting): |
| 2026 | 2025 |
| £ | £ |
| Other operating leases |
| Depreciation - owned assets |
| Depreciation - assets on hire purchase contracts |
| (Profit)/loss on disposal of fixed assets | ( |
) |
| Auditors' remuneration |
| 6. | INTEREST PAYABLE AND SIMILAR EXPENSES |
| 2026 | 2025 |
| £ | £ |
| Bank loan interest |
| Late payment interest |
| Hire purchase interest |
| 7. | TAXATION |
| Analysis of the tax charge |
| The tax charge on the profit for the year was as follows: |
| 2026 | 2025 |
| £ | £ |
| Current tax: |
| UK corporation tax |
| Under/(over) provision prior |
| years | (3,118 | ) | - |
| Total current tax |
| Deferred tax: |
| Deferred tax | ( |
) |
| Over provision in prior years | - | (54,545 | ) |
| Total deferred tax | ( |
) |
| Tax on profit |
| UK corporation tax has been charged at 25% (2025 - 25%). |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 7. | TAXATION - continued |
| Reconciliation of total tax charge included in profit and loss |
| The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is explained below: |
| 2026 | 2025 |
| £ | £ |
| Profit before tax |
| Profit multiplied by the standard rate of corporation tax in the UK of (2025 - |
| Effects of: |
| Expenses not deductible for tax purposes |
| Adjustments to tax charge in respect of previous periods | ( |
) | ( |
) |
| Depreciation on assets not ranking for capital allowances | 91,404 | 21,916 |
| Depreciation on qualifying expenditure revalued | (64,181 | ) | 63,127 |
| Group relief | (45,971 | ) | - |
| Total tax charge | 231,513 | 206,380 |
| Tax effects relating to effects of other comprehensive income |
| 2026 |
| Gross | Tax | Net |
| £ | £ | £ |
| Revaluation release | 13,237 | 13,237 |
| 2025 |
| Gross | Tax | Net |
| £ | £ | £ |
| Revaluation in year | (619,763 | ) | 1,859,289 |
| Underprovision in prior year | (115,069 | ) | (115,069 | ) |
| 2,479,052 | (734,832 | ) | 1,744,220 |
| 8. | DIVIDENDS |
| 2026 | 2025 |
| £ | £ |
| Ordinary shares of £0.01 each |
| Interim | 400,000 | 274,000 |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 9. | TANGIBLE FIXED ASSETS |
| Fixtures |
| Freehold | Plant and | and |
| property | machinery | fittings |
| £ | £ | £ |
| COST OR VALUATION |
| At 1 April 2025 |
| Additions |
| Disposals |
| At 31 March 2026 |
| DEPRECIATION |
| At 1 April 2025 |
| Charge for year |
| Eliminated on disposal |
| At 31 March 2026 |
| NET BOOK VALUE |
| At 31 March 2026 |
| At 31 March 2025 |
| Motor | Computer |
| vehicles | equipment | Totals |
| £ | £ | £ |
| COST OR VALUATION |
| At 1 April 2025 |
| Additions |
| Disposals | ( |
) | ( |
) |
| At 31 March 2026 |
| DEPRECIATION |
| At 1 April 2025 |
| Charge for year |
| Eliminated on disposal | ( |
) | ( |
) |
| At 31 March 2026 |
| NET BOOK VALUE |
| At 31 March 2026 |
| At 31 March 2025 |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 9. | TANGIBLE FIXED ASSETS - continued |
| Cost or valuation at 31 March 2026 is represented by: |
| Fixtures |
| Freehold | Plant and | and |
| property | machinery | fittings |
| £ | £ | £ |
| Valuation in 2025 | 2,595,432 | - | - |
| Cost | 5,167,557 | 239,463 | 325,763 |
| 7,762,989 | 239,463 | 325,763 |
| Motor | Computer |
| vehicles | equipment | Totals |
| £ | £ | £ |
| Valuation in 2025 | - | - | 2,595,432 |
| Cost | 247,323 | 58,962 | 6,039,068 |
| 247,323 | 58,962 | 8,634,500 |
| If freehold land & buildings had not been revalued they would have been included at the following historical cost: |
| 2026 | 2025 |
| £ | £ |
| Cost | 5,077,831 | 5,077,831 |
| Aggregate depreciation | 1,203,717 | 1,102,160 |
| Value of land in freehold land and buildings | 1,000,000 | 1,000,000 |
| Freehold land & buildings were valued on an open market basis on 31 March 2025 by Cushman & Wakefield . |
| If Freehold Property was sold this would result in an additional corporation tax liability of approximately £919,172. |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 9. | TANGIBLE FIXED ASSETS - continued |
| Fixed assets, included in the above, which are held under hire purchase contracts are as follows: |
| Motor |
| vehicles |
| £ |
| COST OR VALUATION |
| At 1 April 2025 |
| and 31 March 2026 |
| DEPRECIATION |
| At 1 April 2025 |
| Charge for year |
| At 31 March 2026 |
| NET BOOK VALUE |
| At 31 March 2026 |
| At 31 March 2025 |
| 10. | FIXED ASSET INVESTMENTS |
| Shares in |
| group |
| undertakings |
| £ |
| COST |
| At 1 April 2025 |
| Disposals | ( |
) |
| At 31 March 2026 |
| NET BOOK VALUE |
| At 31 March 2026 |
| At 31 March 2025 |
| 11. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2026 | 2025 |
| £ | £ |
| Trade debtors |
| Amounts owed by group undertakings |
| Other debtors |
| Directors' current accounts | - | 48,758 |
| Prepayments and accrued income |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 12. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2026 | 2025 |
| £ | £ |
| Bank loans and overdrafts (see note 14) |
| Hire purchase contracts (see note 15) |
| Trade creditors |
| Amounts owed to group undertakings |
| Tax |
| Social security and other taxes |
| Other creditors |
| Accrued expenses |
| 13. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 2026 | 2025 |
| £ | £ |
| Bank loans (see note 14) |
| Hire purchase contracts (see note 15) |
| 14. | LOANS |
| An analysis of the maturity of loans is given below: |
| 2026 | 2025 |
| £ | £ |
| Amounts falling due within one year or on demand: |
| Bank loans |
| Amounts falling due between two and five years: |
| Bank loans |
| Amounts falling due in more than five years: |
| Repayable by instalments |
| Bank loans more 5 years by ins talments | 2,927,494 | 2,984,206 |
| 15. | LEASING AGREEMENTS |
| Minimum lease payments under hire purchase fall due as follows: |
| 2026 | 2025 |
| £ | £ |
| Net obligations repayable: |
| Within one year |
| Between one and five years |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 16. | SECURED DEBTS |
| The following secured debts are included within creditors: |
| 2026 | 2025 |
| £ | £ |
| Bank loans |
| Hire purchase contracts | 151,922 | 179,345 |
| Bank loans and overdraft are secured by a bond and floating charge together with standard security over the Freehold Property. |
| Hire purchase liabilities are secured over the assets concerned. |
| Included in bank loans is a Coronavirus Business Interruption Loan of £46,667. This is supported by a 100% guarantee from the UK Government. |
| 17. | PROVISIONS FOR LIABILITIES |
| 2026 | 2025 |
| £ | £ |
| Deferred tax |
| Other timing differences | 866,197 | 879,433 |
| Accelerated capital allowances | 325,108 | 335,231 |
| 1,191,305 | 1,214,664 |
| Deferred |
| tax |
| £ |
| Balance at 1 April 2025 |
| Provided during year | ( |
) |
| On revaluation reserve release | (13,236 | ) |
| Balance at 31 March 2026 |
| APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 18. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 2026 | 2025 |
| 5 | Ordinary | £1 | 5 | - |
| 2,000 | Ordinary | £0.01 | - | 2 |
| 1 | A | £1 | - | 1 |
| 1 | B | £1 | - | 1 |
| 1 | C | £1 | - | 1 |
| 5 | 5 |
| Shares in all classes have rights and entitlements to dividends. Ordinary shares have voting rights. All other classes of share capital do not have voting rights attached. |
| In the event of liquidation the surplus assets of the Company remaining after the payments of it's liabilities shall be applied in distributing the balance of such assets as follows: |
| (i) first shareholders of A, B, C, D and E shares in amounts equal to the amounts paid up by them on such shares; and |
| (ii) second, the holders of the Ordinary shares in proportion to the numbers of the Ordinary shares held by them. |
| 19. | RESERVES |
| Retained | Revaluation |
| earnings | reserve | Totals |
| £ | £ | £ |
| At 1 April 2025 | 3,610,289 |
| Profit for the year |
| Dividends | ( |
) | ( |
) |
| Revaluation reserve release | 52,946 | (39,709 | ) | 13,237 |
| At 31 March 2026 | 3,992,321 |
| 20. | RELATED PARTY DISCLOSURES |
| Roddinghead Investments (No2) Ltd |
| A company in which L J Coyle is a director and shareholder |
| During the year the company paid rents of £10,050 (2025 - £5,550) to Roddinghead Investments (No2) Ltd. |
| These transactions were conducted under normal commercial terms. |